54600 Federal Register / Vol. 73, No. 184 / Monday, September 22, 2008 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis Meeting (ACET) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following council 

meeting. 

Times and Dates: 

8:30 a.m.–5:30 p.m., October 7, 2008. 

8:30 a.m.–2 p.m., October 8, 2008. 

Place: Corporate Square, Building 8, 

1st Floor Conference Room, Atlanta, 

Georgia 30333, Telephone (404) 639– 

8317. 

Status: Open to the public, limited 

only by the space available. The meeting 

room accommodates approximately 100 

people. 

Purpose: This council advises and 

makes recommendations to the 

Secretary of Health and Human 

Services, the Assistant Secretary for 

Health, and the Director, CDC, regarding 

the elimination of tuberculosis. 

Specifically, the Council makes 

recommendations regarding policies, 

strategies, objectives, and priorities; 

addresses the development and 

application of new technologies; and 

reviews the extent to which progress has 

been made toward eliminating 

tuberculosis. 

Matters to be Discussed: Agenda items 

include issues pertaining to update on 

nucleic acid amplification guidelines; 

update on interferon gamma release 

assays guidelines; update on the 

isolation guidelines; update on travel 

restrictions guidelines and other related 

tuberculosis issues. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Margie Scott-Cseh, Coordinating Center 

for Infectious Diseases, Strategic 

Business Unit, 1600 Clifton Road, NE., 

M/S E–07, Atlanta, Georgia 30333, 

Telephone (404) 639–8317. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

Notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: September 15, 2008. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. E8–22040 Filed 9–19–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–D–0372] 

Global Harmonization Task Force, 

Study Groups 1 and 5; Proposed and 

Final Documents; Availability; 

Correction 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; correction. 

SUMMARY: The Food and Drug 

Administration (FDA) is correcting a 

notice that appeared in the Federal 

Register of July 11, 2008 (73 FR 39968). 

The notice announced the availability of 

Global Harmonization Task Force 

documents entitled ‘‘Role of Standards’’ 

and ‘‘Clinical Investigations.’’ The 

notice was published with an incorrect 

document number. This document 

corrects that number. 

FOR FURTHER INFORMATION CONTACT: Paul 

Gadiock, Center for Devices and 

Radiological Health (HFZ–215), Food 

and Drug Administration, 1350 Piccard 

Dr., Rockville, MD 20850, 240–276– 

2343. 

SUPPLEMENTARY INFORMATION: In FR Doc. 

E8–15797, appearing on page 39968 in 

the Federal Register of Friday, July 11, 

2008, the following correction is made: 

1. On page 39968, in the third 

column, in the third paragraph, in the 

8th and 9th lines, ‘‘SG5(PD)/N37:2007’’ 

is corrected to read ‘‘SG5(PD)/ 

N3R7:2007.’’ 

Dated: September 11, 2008. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E8–22094 Filed 9–19–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Biophysics of Neural 

Systems Study Section, October 2, 2008, 

8 am to October 3, 2008, 5 pm, One 

Washington Circle Hotel, One 

Washington Circle, Washington, DC 

20037 which was published in the 

Federal Register on September 9, 2008, 

73 FR 52395–52397. 

The meeting will be held one day 

only October 2, 2008, from 8 am to 8 

pm. The meeting location remains the 

same. The meeting is closed to the 

public. 

Dated: September 15, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–22055 Filed 9–19–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive And Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; R13 Conference 

Application. 

Date: October 23, 2008. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, Two 

Democracy Plaza, 6707 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: D.G. Patel, PhD, Scientific 

Review Officer, Review Branch, DEA, 

NIDDK, National Institutes of Health, Room 

756, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–7682, 

pateldg@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Ancillary Study for 

PKD. 

Date: October 27, 2008. 

Time: 12 p.m. to 2 p.m. 


sroberts on PROD1PC70 with NOTICES